Zhejiang Jiuzhou Pharm Co Ltd - Asset Resilience Ratio

Latest as of June 2022: 0.01%

Zhejiang Jiuzhou Pharm Co Ltd (603456) has an Asset Resilience Ratio of 0.01% as of June 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Zhejiang Jiuzhou Pharm Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥1.06 Million
≈ $155.05K USD Cash + Short-term Investments

Total Assets

CN¥7.93 Billion
≈ $1.16 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2010–2021)

This chart shows how Zhejiang Jiuzhou Pharm Co Ltd's Asset Resilience Ratio has changed over time. See Zhejiang Jiuzhou Pharm Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Jiuzhou Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 603456 market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.06 Million 0.01%
Total Liquid Assets CN¥1.06 Million 0.01%

Asset Resilience Insights

  • Limited Liquidity: Zhejiang Jiuzhou Pharm Co Ltd maintains only 0.01% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Zhejiang Jiuzhou Pharm Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Jiuzhou Pharm Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
Drug Manufacturers - Specialty & Generic 0.76%
Eris Lifesciences Limited
NSE:ERIS
Drug Manufacturers - Specialty & Generic 0.58%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.01%
Lotus Pharmaceutical Co Ltd
TW:1795
Drug Manufacturers - Specialty & Generic 0.49%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 11.69%
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
Drug Manufacturers - Specialty & Generic 18.70%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%
Sun Pharma Advanced Research Company Limited
NSE:SPARC
Drug Manufacturers - Specialty & Generic 0.64%

Annual Asset Resilience Ratio for Zhejiang Jiuzhou Pharm Co Ltd (2010–2021)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Jiuzhou Pharm Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2021-12-31 0.37% CN¥26.06 Million
≈ $3.81 Million
CN¥7.04 Billion
≈ $1.03 Billion
-0.18pp
2020-12-31 0.55% CN¥27.45 Million
≈ $4.02 Million
CN¥5.00 Billion
≈ $731.92 Million
-0.36pp
2018-12-31 0.91% CN¥30.00 Million
≈ $4.39 Million
CN¥3.30 Billion
≈ $483.61 Million
-12.43pp
2015-12-31 13.34% CN¥445.00 Million
≈ $65.12 Million
CN¥3.34 Billion
≈ $488.05 Million
+8.81pp
2014-12-31 4.53% CN¥100.00 Million
≈ $14.63 Million
CN¥2.21 Billion
≈ $323.13 Million
+3.58pp
2013-12-31 0.95% CN¥14.66 Million
≈ $2.15 Million
CN¥1.55 Billion
≈ $226.96 Million
+0.65pp
2012-12-31 0.29% CN¥3.94 Million
≈ $577.26K
CN¥1.34 Billion
≈ $196.57 Million
+0.08pp
2010-12-31 0.21% CN¥1.81 Million
≈ $264.45K
CN¥855.97 Million
≈ $125.25 Million
--
pp = percentage points

About Zhejiang Jiuzhou Pharm Co Ltd

SHG:603456 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.71 Billion
CN¥11.67 Billion CNY
Market Cap Rank
#6858 Global
#1532 in China
Share Price
CN¥13.12
Change (1 day)
+1.16%
52-Week Range
CN¥12.18 - CN¥21.87
All Time High
CN¥60.21
About

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecule, drug product, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and … Read more